HONOLULU - October 29, 2009 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced new study results on INTUNIV™ (guanfacine) Extended Release Tablets, at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results